Receptor de adenosina
Os receptores de adenosina são uma classe de GPCRs que respondem ao nucleosídeo endógeno adenosina. Esses receptores estão envolvidos na regulação de vários processos fisiológicos, incluindo função cardiovascular, ciclos de sono-vigília e respostas imunes. Moduladores de receptores de adenosina têm potencial terapêutico no tratamento de condições como arritmias cardíacas, inflamação e doenças neurodegenerativas. Na CymitQuimica, oferecemos uma seleção de moduladores de receptores de adenosina de alta qualidade para apoiar sua pesquisa em biologia cardiovascular, neurociência e imunologia.
Foram encontrados 242 produtos de "Receptor de adenosina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trabodenoson
CAS:<p>Trabodenoson (INO-8875) is a selective and potent adenosine A1 receptor agonist, an adenosine analog, for the study of primary open-angle glaucoma.</p>Fórmula:C15H20N6O6Pureza:99.94%Cor e Forma:SolidPeso molecular:380.36Blontuvetmab
CAS:<p>Blontuvetmab (AT 004), a caninized CD20 monoclonal antibody, is utilized in the study of Canine B-cell lymphoma [1].</p>Cor e Forma:LiquidTC-G 1004
CAS:<p>adenosine A2A receptors antagonist</p>Fórmula:C22H27N7O2Pureza:98%Cor e Forma:SolidPeso molecular:421.5A2AR-agonist-1
CAS:<p>A2AR-agonist-1 targets A2A Receptor/ENT1 for neuroprotection; potent with Ki of 4.39 (A2AR), 3.47 (ENT1).</p>Fórmula:C20H22N6O4Pureza:99.9%Cor e Forma:SolidPeso molecular:410.43hA2A/hCA XII modulator 1
CAS:<p>Potent hA2AAR antagonist & hCA XII inhibitor; Ki: hA2AAR 6.4 nM, hCA XII 6.2 nM. Possible cancer research use.</p>Fórmula:C24H19N7O4SCor e Forma:SolidPeso molecular:501.52IHCH-3064
CAS:<p>IHCH-3064: dual-action cancer immunotherapy, A2AR affinity (Ki 2.2 nM), selective HDAC1 inhibitor (IC50 80.2 nM).</p>Fórmula:C25H21N9O2Cor e Forma:SolidPeso molecular:479.49MRS 1334
CAS:<p>antagonist for the human adenosine A3 receptor</p>Fórmula:C31H26N2O6Pureza:98%Cor e Forma:SolidPeso molecular:522.55LUF6000
CAS:<p>LUF6000 is an allosteric modulator of the human A3 adenosine receptor (AR).</p>Fórmula:C22H20Cl2N4Cor e Forma:SolidPeso molecular:411.33A2A/A1 AR antagonist-1
CAS:<p>A2A/A1 AR antagonist-1 is a potent dual antagonist for ischemic stroke research with Ki values of 5.58 nM (A2A) and 24.2 nM (A1).</p>Fórmula:C15H12N6O2Cor e Forma:SolidPeso molecular:308.29LUF 5834
CAS:<p>A2A and A2B adenosine receptor partial agonist</p>Fórmula:C17H12N6OSPureza:98%Cor e Forma:SolidPeso molecular:348.385'-(N-Cyclopropyl)carboxamidoadenosine
CAS:<p>adenosine A2 receptor agonist</p>Fórmula:C13H16N6O4Pureza:98%Cor e Forma:SolidPeso molecular:320.3A1AR antagonist 5
CAS:<p>A1AR antagonist 5 (compound 20) is a potent and selective antagonist of A1 adenosine receptor (A1AR) with a pKi of 6.11 and a pIC 50 of 5.83 [1].</p>Fórmula:C17H15ClN4OCor e Forma:SolidPeso molecular:326.78A1AR antagonist 3
CAS:<p>Compound 13: selective A1AR antagonist, Ki human A1: 9.69 nM, rat A1: 0.529 nM, useful for neurological research.</p>Fórmula:C25H20N2O3SCor e Forma:SolidPeso molecular:428.5XCC
CAS:<p>XCC is an Adenosine receptor antagonist.</p>Fórmula:C19H22N4O5Pureza:98%Cor e Forma:SolidPeso molecular:386.4A1AR antagonist 4
CAS:<p>Compound 22: A1AR antagonist, pIC50 5.51, pKi 6.29, potent and selective.</p>Fórmula:C23H25N3O2Cor e Forma:SolidPeso molecular:375.46MRS1097
CAS:<p>MRS1097 is a selective antagonist A3 adenosine receptor.</p>Fórmula:C26H27NO4Pureza:98%Cor e Forma:SolidPeso molecular:417.5MRS-1191
CAS:<p>MRS-1191 is an effective and selective A3 adenosine receptor antagonist (KB: 92 nM, a Ki: 31.4 nM for human A3 receptor and an IC50: 120 nM for CHO cells).</p>Fórmula:C31H27NO4Cor e Forma:SolidPeso molecular:477.55Apadenoson
CAS:<p>Apadenoson: potent A2 agonist, A3 inhibitor (IC 45 nM), anti-inflammatory, for neurological research.</p>Fórmula:C23H30N6O6Pureza:98%Cor e Forma:SolidPeso molecular:486.52Lu AA 47070
CAS:<p>adenosine A2A receptor antagonist</p>Fórmula:C17H20F2N3O6PSPureza:98%Cor e Forma:SolidPeso molecular:463.39A1AR antagonist 2
CAS:<p>Compound 18h is a potent A1 adenosine receptor blocker with Ki of 1.49 nM for hA1, 10.2 nM for hA2A, 50.1 nM for hA2B.</p>Fórmula:C17H12N4OCor e Forma:SolidPeso molecular:288.3Adenosine receptor inhibitor 1
CAS:<p>Potent, selective adenosine receptor blocker with strong affinity, especially A2A (Ki 68.5 nM). Promising for cancer, neurodegeneration study.</p>Fórmula:C17H19ClFN5O3Cor e Forma:SolidPeso molecular:395.82A1/A3 AR antagonist 2
CAS:<p>The compound is an a1/a3 adenosine receptor antagonist, which helps to treat (neurological) inflammatory diseases.</p>Fórmula:C22H16N2O3SCor e Forma:SolidPeso molecular:388.44AB-MECA
CAS:<p>AB-MECA is a high affinity A3 adenosine receptor agonist. It has high affinity for recombinant A1 and A3 receptors.</p>Fórmula:C18H21N7O4Pureza:98%Cor e Forma:SolidPeso molecular:399.4A2AAR/HDAC-IN-1
CAS:<p>A2AAR/HDAC-IN-1 (compound 14c) is an orally active, balanced A2AAR/HDAC dual inhibitor of A2AAR (Ki: 163.5 nM), HDAC1 (IC50: 145.3 nM). effect.</p>Fórmula:C24H21N7O2Cor e Forma:SolidPeso molecular:439.47LASSBio-1359
CAS:<p>LASSBio-1359 is an adenosine receptor agonist. It acts by inducing relaxation of the corpus cavernosum. It also acts as a novel selective phosphodiesterase.</p>Fórmula:C17H18N2O3Pureza:98%Cor e Forma:SolidPeso molecular:298.34PSB 11 hydrochloride
CAS:<p>PSB 11 hydrochloride is a human adenosine A3 receptor antagonist.</p>Fórmula:C16H18ClN5OPureza:98%Cor e Forma:SolidPeso molecular:331.8Adenosine receptor antagonist 3
CAS:<p>Adenosine receptor antagonist 3 has the potential for cancer disease research which is a potent adenosine receptor antagonist [1].</p>Fórmula:C16H14N6SCor e Forma:SolidPeso molecular:322.39Adentri
CAS:<p>Adentri is a novel antagonist of adenosine A1 receptor with unique diuretic activity.</p>Fórmula:C18H24N4O3Pureza:98%Cor e Forma:SolidPeso molecular:344.41A2A receptor antagonist 3
CAS:<p>A2A receptor antagonist 3 (Example 92) is an adenosine A2a receptor antagonist (Ki: 0.4 nM). receptor (Ki: 1467 nM).</p>Fórmula:C26H26N6O2Cor e Forma:SolidPeso molecular:454.52MRS1186
CAS:<p>MRS1186 is an effective and selective antagonist of the human Adenosine A3 receptor (Ki: 7.66 nM).</p>Fórmula:C16H12ClN5O2Pureza:98%Cor e Forma:SolidPeso molecular:341.75Adenosine receptor A1 antagonist 5
CAS:<p>1,3-Dipropyl-8-phenylxanthine is an adenosine antagonist, oxypurine, insecticide, and reduces high blood pressure.</p>Fórmula:C17H20N4O2Pureza:99.97%Cor e Forma:SolidPeso molecular:312.37MRS1177
CAS:<p>MRS1177 is an effective and selective antagonist of the human Adenosine A3 receptor (hA3AR) (Ki: 0.3 nM).</p>Fórmula:C20H12ClN5O2Pureza:98%Cor e Forma:SolidPeso molecular:389.79XU1
CAS:<p>XU1（Benzo[c][1,8]naphthyridin-6(5h)-One） is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or</p>Fórmula:C12H8N2OPureza:98.58% - 99.59%Cor e Forma:SolidPeso molecular:196.2HEMADO
CAS:<p>HEMADO is a potent and selective agonist of adenosine A3 receptor (Ki: 1.1 nM at the human A3 subtype).</p>Fórmula:C17H23N5O4Pureza:98%Cor e Forma:SolidPeso molecular:361.4A1AR antagonist 6
CAS:<p>A1AR antagonist 6 (compound 15) is a potent and selective antagonist of A1 adenosine receptor(A1AR) with a pKi of 7.13 and a pIC 50 of 6.38[1].</p>Fórmula:C17H15N3O2Cor e Forma:SolidPeso molecular:293.32Lu AA41063
CAS:<p>Lu AA41063 is a potent and selective antagonist of the hA2A receptor.</p>Fórmula:C16H17F2N3O2SCor e Forma:SolidPeso molecular:353.39Neladenoson dalanate HCl
CAS:<p>Neladenoson dalanate HCl is a potent, selective, orally active partial agonist of adenosine A1 receptor (EC50: 0.1 nM).</p>Fórmula:C35H35Cl2N7O4S2Pureza:98%Cor e Forma:SolidPeso molecular:752.73A3AR antagonist 1
CAS:<p>A3AR antagonist 1 is a potent and selective human A3adenosine receptor (AR) antagonist (Ki: 4.63) and has no affinity for the rat A3AR.</p>Fórmula:C32H24N4O4SCor e Forma:SolidPeso molecular:560.62Adenosine receptor antagonist 2
CAS:<p>Adenosine receptor antagonist 2 is an orally active A2a (IC50: 1 nM), A2b (IC50: 3 nM) adenosine receptor antagonist that exhibits antitumour effects.</p>Fórmula:C23H21FN8OCor e Forma:SolidPeso molecular:444.46CAY10498
CAS:<p>A3 AR antagonist CAY10498, with Ki of 37 nM, is 60-200x selective over A1/A2A receptors; no dedifferentiation effects shown.</p>Fórmula:C18H20N6Cor e Forma:SolidPeso molecular:320.39VUF8507
CAS:<p>Vuf8507 is an allosteric regulator of adenosine receptor.</p>Fórmula:C21H15N3OCor e Forma:SolidPeso molecular:325.36PD 81723
CAS:<p>Allosteric potentiator at the adenosine A1 receptor</p>Fórmula:C14H12F3NOSPureza:98%Cor e Forma:SolidPeso molecular:299.31Sipagladenant
CAS:<p>Sipagladenant: oral inverse agonist for A2A adenosine receptor, may aid frontal lobe dysfunction research.</p>Fórmula:C20H19N3O4SCor e Forma:SolidPeso molecular:397.45SCH-202676 HBr
CAS:<p>SCH-202676 HBr is an allosteric agonist. It also an GPCR antagonist.</p>Fórmula:C15H13N3SPureza:98%Cor e Forma:SolidPeso molecular:267.35A3AR antagonist 2
CAS:<p>A3AR antagonist 2 is a potent antagonist of the human A3 adenosine receptor, exhibiting a Ki value of 4.54 nM.</p>Fórmula:C22H16N6O3Cor e Forma:SolidPeso molecular:412.4TH-162
CAS:<p>TH-162 (R)-PIA is an A1 adenosine receptor agonist with ~100× higher affinity than its (+)-isomer.</p>Fórmula:C19H23N5O4Cor e Forma:SolidPeso molecular:385.42PQ-69
CAS:<p>PQ-69 is a selective adenosine A1 receptor antagonist with inverse agonist activity.</p>Fórmula:C20H19FN4OCor e Forma:SolidPeso molecular:350.39MRS 1523
CAS:<p>MRS 1523: selective adenosine A3 antagonist, Ki 18.9/113 nM (human/rat), blocks N-type Ca channels & inhibits action potentials in rat DRG neurons.</p>Fórmula:C23H29NO3SPureza:98%Cor e Forma:SolidPeso molecular:399.55Inupadenant
CAS:<p>Inupadenant is an orally active, highly selective A2A receptor antagonist. Inupadenant is not brain-penetrant. Inupadenant has potent anti-tumor activity[1].</p>Fórmula:C25H26F2N8O4S2Cor e Forma:SolidPeso molecular:604.65CAY10680
CAS:<p>CAY10680 inhibits MAO-B (IC50=34.9 nM) & A2A receptors (Ki=39.5 nM), sparing other adenosine types & MAO-A, may treat Parkinson's.</p>Fórmula:C18H16N2O2SCor e Forma:SolidPeso molecular:324.4
